Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
- Status
- COMPLETED
- Phase
- PHASE1
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
- Status
- COMPLETED
- Phase
- N/A
TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer
- Status
- COMPLETED
- Phase
- NA
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Neoadjuvant Therapy for Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
- Status
- TERMINATED
- Phase
- NA
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
- Status
- TERMINATED
- Phase
- N/A
Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2